A Study of Potential Treatment-Responsive Biomarkers and Clinical Outcomes in Hunter Syndrome

NCT04007536 · clinicaltrials.gov ↗

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Mucopolysaccharidosis II

Interventions

OTHER: No Intervention

Sponsor

Denali Therapeutics Inc.